Jayaraj Arjun, Duncan Audra A, Kalra Manju, Bower Thomas C, Gloviczki Peter
Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.
Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.
Ann Vasc Surg. 2018 Aug;51:147-149. doi: 10.1016/j.avsg.2018.02.029. Epub 2018 May 15.
Cervical rib can often be symptomatic causing neurogenic thoracic outlet syndrome (nTOS). Surgical treatment involves rib resection through a supraclavicular, transaxillary or combined approach. We review outcomes of different approaches and describe our technique of transaxillary resection through a video.
A single-center retrospective review of perioperative and short-term outcomes in subjects undergoing cervical rib resection for nTOS between 1994 and 2013 was performed.
Of the 75 operations performed for nTOS, 40% (30 procedures in 29 patients) required resection of cervical ribs. The first and cervical ribs were removed in 24 operations, whereas only the cervical rib was resected in 6. Scalenectomy was performed in all patients. Thirteen (43%) procedures were performed with a supraclavicular-only (SC group) approach, 9 (30%) with a transaxillary-only (TA group) approach, and 8 (27%) with a combined approach (TA + SC group). Incidence of persistent nTOS symptoms occurred in 3 (23%) of SC patients, 1 (13%) TA patient, and 2 (25%) TA + SC patients (P > 0.05). Recurrence of symptoms was noted in one patient (8%) in the SC group at 1-year follow-up. No patient required operative reintervention.
Resection of cervical ribs and/or first ribs in the treatment of nTOS can be safely performed through SC, TA, or a combined approach. In young patients, a TA incision should be considered to avoid a neck incision, with outcomes similar to alternate approaches.
颈肋常常会引发症状,导致神经源性胸廓出口综合征(nTOS)。手术治疗包括通过锁骨上、经腋窝或联合入路切除肋骨。我们回顾了不同入路的治疗结果,并通过一段视频描述我们的经腋窝切除技术。
对1994年至2013年间因nTOS接受颈肋切除的患者的围手术期和短期结果进行单中心回顾性研究。
在为nTOS进行的75例手术中,40%(29例患者共30例手术)需要切除颈肋。24例手术中切除了第一肋和颈肋,而仅切除颈肋的有6例。所有患者均进行了斜角肌切除术。13例(43%)手术采用单纯锁骨上入路(SC组),9例(30%)采用单纯经腋窝入路(TA组),8例(27%)采用联合入路(TA + SC组)。SC组3例(23%)、TA组1例(13%)、TA + SC组2例(25%)出现持续性nTOS症状(P > 0.05)。SC组1例患者(8%)在1年随访时出现症状复发。无患者需要再次手术干预。
在治疗nTOS时,切除颈肋和/或第一肋可通过SC、TA或联合入路安全进行。对于年轻患者,应考虑采用TA切口以避免颈部切口,其治疗结果与其他入路相似。